When it comes to immunology, we’re thinking bigger and digging deeper than a single drug.
Global Head of R&D
Our immunology pipeline
Our teams use real-world, molecular, and clinical data to advance precision medicine, and investigate:
- pathways common to systemic diseases like asthma and atopic dermatitis
- peripheral inflammatory diseases like rheumatoid arthritis
- autoimmune challenges in type 1 diabetes and cancer
Follow the Science
Type 2 inflammation
Our goal: to give people their lives back by calming excessive inflammation–without compromising their ability to fight infection.
With our partner Regeneron, we study how blocking two interleukins1 can help calm type 2 inflammation, a driver of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and other conditions.
Beyond type 2 inflammation
Single-cell genomics, genetics, and proteomics help us understand exactly what makes patients different from one another.
How can we restore the delicate balance between a protective immune response and destructive autoimmunity?2
Can we stop a cascade of inflammation without compromising immunity, by blocking one protein?3